Myocardial perfusion scintigraphy for the diagnosis and management of angina and
KEYWORDS: spect, cad, patients, committee, studies, secg, cardiac, cost, myocardial, diagnostic, clinical, strategy, assessment, nhs, considered

• Tyco Healthcare UK Ltd Professional or specialist, and patient or carer groups: • Action Heart • Association of British Health-Care Industries • British Cardiac Patients Association • British Cardiac Society • British Cardiovascular Interventional Society • British Heart Foundation • British Nuclear Cardiology Society • British Nuclear Medicine Society • Department of Health • Fareham and Gosport Primary Care Trust • Maidstone Weald Primary Care Trust • Royal College of Physicians • Royal College of Radiologists • Society for Cardiological Science and Technology • Welsh Assembly Government Commentator organisations (without the right of appeal): • Cochrane Heart Group • Institute of Nuclear Medicine • Institute of Physics and Engineering in Medicine • NHS Confederation • NHS Information Authority • NHS Purchasing and Supply Agency • NHS Quality Improvement Scotland The following individuals were selected from clinical expert and patient advocate nominations from the professional or specialist, and patient or carer groups. They participated in the Appraisal Committee discussions and provided evidence to inform the Appraisal Committee's deliberations. They gave their expert personal view on myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction by attending the initial Committee discussion and/or providing written evidence to the
